Body weight loss as a prognostic and predictive factor in previously treated patients with metastatic gastric cancer: post hoc analyses of the randomized phase III TAGS trial.

MLA

Ghidini, Michele, et al. “Body Weight Loss as a Prognostic and Predictive Factor in Previously Treated Patients with Metastatic Gastric Cancer: Post Hoc Analyses of the Randomized Phase III TAGS Trial.” Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol. 26, no. 4, July 2023, pp. 626–37. EBSCOhost, https://doi.org/10.1007/s10120-023-01393-2.

APA

Ghidini, M., Hochster, H., Doi, T., Van Cutsem, E., Makris, L., Takahashi, O., Benhadji, K. A., & Mansoor, W. (2023). Body weight loss as a prognostic and predictive factor in previously treated patients with metastatic gastric cancer: post hoc analyses of the randomized phase III TAGS trial. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 26(4), 626–637. https://doi.org/10.1007/s10120-023-01393-2

Chicago

Ghidini, Michele, Howard Hochster, Toshihiko Doi, Eric Van Cutsem, Lukas Makris, Osamu Takahashi, Karim A Benhadji, and Wasat Mansoor. 2023. “Body Weight Loss as a Prognostic and Predictive Factor in Previously Treated Patients with Metastatic Gastric Cancer: Post Hoc Analyses of the Randomized Phase III TAGS Trial.” Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 26 (4): 626–37. doi:10.1007/s10120-023-01393-2.